Eric Perouzel

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Extracorporeal Membrane Oxygenation

Herpes Simplex Virus

Candida Albicans

Immune Response

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

InvivoGen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

InvivoGen May 10 2006

France

Chief Operating Officer

Publications

Seung-Hwan Lee, Young-Ho Choi, Soon Myung Kang, Min-Gyu Lee, Arnaud Debin, Eric Perouzel, Seung-Beom Hong, Dong-Ho Kim
The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell Infiltration. Cancers 15 (24) (2023)
Seung-Hwan Lee, Young-Ho Choi, Soon Myung Kang, Min-Gyu Lee, Arnaud Debin, Eric Perouzel, Seung-Beom Hong, Dong-Ho Kim
The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell Infiltration. Cancers 15 (24) (2023)
Morten Kelder Skouboe, Alice Knudsen, Line S Reinert, Cedric Boularan, Thierry Lioux, Eric Perouzel, Martin K Thomsen, Soren Riis Paludan
STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice. PLoS pathogens 14 (4) (2018)
Alice Gutjahr, Laura Papagno, Francesco Nicoli, Alain Lamoureux, Fabienne Vernejoul, Thierry Lioux, Emma Gostick, David A Price, Gérard Tiraby, Eric Perouzel, Victor Appay, Bernard Verrier, Stéphane Paul
Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses. Journal of immunology (Baltimore, Md. : 1950) 198 (11) (2017)